about
Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemiaCombined fluorescent-chromogenic in situ hybridization for identification and laser microdissection of interphase chromosomes.S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia.Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish populationA systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.Pharmacogenetics of childhood acute lymphoblastic leukemia.A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility.Expression of the DYRK1A gene correlates with its 3D positioning in the interphase nucleus of Down syndrome cells.MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence.Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia.Biological activity of complexes derived from thiophene-2-carbaldehyde thiosemicarbazone. Crystal structure of [Ni(C(6)H(6)N(3)S(2))(2)].Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.Errors in the interpretation of copy number variations due to the use of public databases as a reference.Research commentary regarding Savage et al. entitled "Genome-wide association study identifies two susceptibility loci for osteosarcoma".Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.Genetic susceptibility in childhood acute lymphoblastic leukemia.Genetic typing with HUMTH01, HUMVWA31A and HUMFES/FPS short tandem repeat loci, D1S80 variable number tandem repeat locus and HLA-DQ alpha of recent and from XII-XIII centuries spongy bone.PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort.The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.Erratum to: Potential relationship between single nucleotide polymorphisms used in forensic genetics and diseases or other traits in European population.Polymorphisms in miRNA processing genes and their role in osteosarcoma risk.Chromosome instability in lymphocytes of children with coeliac disease.Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.SLC19A1 hot spot for MTX plasma concentration.Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.Letter regarding Wang et al. entitled "Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systematic review and meta-analysis".Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility.Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility.Re: novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.Newborn genetic identification: a protocol using microsatellite DNA as an alternative to footprintingPopulation study of 3 STR loci in the Basque Country (northern Spain)Alpha-1-Antitrypsin Phenotypes among Breast Cancer Patients in the Basque PopulationThe (8-thiotheophyllinate) (triphenylphosphine) gold (1), (tTAUP): a new gold complex as an anticancer agentNo Evidence for an Association between Glyoxalase I and Haptoglobin in Nine Spanish Populations
P50
Q28540685-2CCFB451-6302-4EA1-B2EC-1CDD60699621Q34658220-288C0FA5-F7DD-4504-8306-6204EFD7B8BAQ35108120-6E9DB928-2FA5-469C-90BB-83EFF97EA248Q35582415-35F736F8-59CF-49D9-B0E1-384F5C6D3155Q36365728-417422B4-7F4D-488A-8C5A-BD106BD3F868Q38054428-4811C018-9569-4170-86BE-CADAF5D27D4EQ38243175-52972737-E962-4378-B6B5-0DA809A5BE55Q38839781-CFBC51A8-AE46-4B7A-B8CD-1C6329857173Q38913693-B3662BC3-DA07-4BD3-B5B1-A50715D32D45Q39230513-9EEE55D2-4482-4620-878E-1282DA4B8F8AQ39894765-3EA984E7-61A4-4CEC-8A5A-B106324AE540Q42746762-F503D595-8687-4854-A9CB-484DDB63DF38Q43744240-35588991-EF08-4B10-9754-A015ECE47A18Q43816514-BC662916-4EE5-4FAA-A172-699B16067440Q44591034-D9587761-5AE7-43EF-A3A1-BDE7A994DD36Q46853649-3BC68AF2-CD29-4FAE-9926-717A26EB08A5Q47177557-F1ABDAF0-B037-4ED2-B312-131C74F45440Q47193441-A1EFF01F-F7E8-4D59-A3F2-B8451394EF83Q47195297-2806D1BB-BDCF-49DA-9E05-3B800F4334BCQ47201317-DB09A9BD-3118-4A8E-BBA5-B8EFC62F9758Q47206896-D3184D74-AFB9-4C64-927C-64C141480367Q47267570-497A547B-B5B6-48AE-9E70-4348A51418B7Q47310338-95FC20E1-C69A-4E52-827D-E67325C6E201Q47358258-4540CAB1-D9C0-4D8B-993A-03A73FE42FF2Q47390783-83E748C6-F605-4660-B047-B679BC4C5229Q47438993-9CAF65DE-17B2-45BC-AE27-9DB4D8193DE5Q47589856-4C9BFC42-FDBD-40AA-AE87-467548FA4BF6Q47592832-2203B189-01BB-43CF-8176-EC20A79E6DE8Q47608710-51ED4A39-8106-420C-9DAD-030D1542DAB0Q47645513-039AB5DB-1C93-48D5-AC2C-8FE77A575C39Q47657846-9864BFE2-7A6C-42DA-85A2-0525CFBFD88AQ47663573-11A772C5-B3CA-4D6A-97C0-0E0E40EA6483Q47722451-4F195A61-4EDA-419E-A4FF-9A88A9D605DAQ47722492-2AD4D163-AFCB-45C0-A732-0994451755CDQ52690565-8CE9D8E0-A3CF-4C5C-AA70-FC27D24C7B8EQ60475947-CC117CE6-D588-4BF4-BA03-754C7B565E4EQ60475956-55F9A947-C3F1-4E62-8078-393BB5D85614Q60475958-C8ED3B86-82A1-4BBB-82B8-028FA1B7856AQ60475960-3A9C4739-5276-42AE-9AC1-EF69BB369A5FQ60475973-46831537-428A-44F1-B5C0-F280E3857344
P50
description
researcher
@en
wetenschapper
@nl
name
A Garcia-Orad
@ast
A Garcia-Orad
@en
A Garcia-Orad
@nl
type
label
A Garcia-Orad
@ast
A Garcia-Orad
@en
A Garcia-Orad
@nl
prefLabel
A Garcia-Orad
@ast
A Garcia-Orad
@en
A Garcia-Orad
@nl
P106
P31
P496
0000-0002-5575-3080